Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 436 AL 450

PUBMED

Therapeutics in Huntington's Disease.

Killoran A, Biglan KM.

Curr Treat Options Neurol. 2012 Feb 8. [Epub ahead of print]

0

0

0

PUBMED

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.

Juopperi TA, Kim WR, Chiang CH, Yu H, Margolis RL, Ross CA, Ming GL, Song H.

Mol Brain. 2012 May 21;5:17. doi: 10.1186/1756-6606-5-17.

0

0

0

PUBMED

Chorea as the first sign in a patient with elderly-onset systemic lupus erythematosus.

Ariizumi Y, Ozawa T, Tokutake T, Kawachi I, Hirose M, Katada S, Igarashi S, Tanaka K, Nishizawa M.

Case Rep Neurol Med. 2012;2012:317082. doi: 10.1155/2012/317082.

0

0

0

PUBMED

Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.

Reddy PH, Shirendeb UP.

Biochim Biophys Acta. 2012 Feb;1822(2):101-10. doi: 10.1016/j.bbadis.2011.10.016. Review.

0

0

0

PUBMED

N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.

Sandhir R, Sood A, Mehrotra A, Kamboj SS.

Neurodegener Dis. 2012;9(3):145-57. doi: 10.1159/000334273.

0

0

0

PUBMED

Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease.

Chen LW, Horng LY, Wu CL, Sung HC, Wu RT.

Neuropharmacology. 2012 Sep;63(4):719-32. doi: 10.1016/j.neuropharm.2012.05.019.

0

0

0

PUBMED

Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.

Kovalenko M, Dragileva E, St Claire J, Gillis T, Guide JR, New J, Dong H, Kucherlapati R, Kucherlapati MH, Ehrlich ME, Lee JM, Wheeler VC.

PLoS One. 2012;7(9):e44273. doi: 10.1371/journal.pone.0044273.

0

0

0

PUBMED

Parkinsonian signs and symptoms in adults with a history of Sydenham's chorea.

Barreto LB, Maciel RO, Maia DP, Teixeira AL, Cardoso F.

Parkinsonism Relat Disord. 2012 Jun;18(5):595-7. doi: 10.1016/j.parkreldis.2011.11.002.

0

0

0

PUBMED

Abnormal spinal cord pain processing in Huntington's disease. The role of the diffuse noxious inhibitory control.

Perrotta A, Serpino C, Cormio C, Serrao M, Sandrini G, Pierelli F, de Tommaso M.

Clin Neurophysiol. 2012 Aug;123(8):1624-30. doi: 10.1016/j.clinph.2012.01.012.

0

0

0

PUBMED

Brain metabolite alterations and cognitive dysfunction in early Huntington's disease.

Unschuld PG, Edden RA, Carass A, Liu X, Shanahan M, Wang X, Oishi K, Brandt J, Bassett SS, Redgrave GW, Margolis RL, van Zijl PC, Barker PB, Ross CA.

Mov Disord. 2012 Jun;27(7):895-902. doi: 10.1002/mds.25010.

0

0

0

PUBMED

Abnormal apocrine secretory cell mitochondria in a Huntington disease patient.

Sidiropoulos C, LeWitt P, Hashimoto K.

J Neurol Sci. 2012 Dec 15;323(1-2):261-3. doi: 10.1016/j.jns.2012.08.034.

0

0

0

PUBMED

A 60-year-old woman with chorea and weight loss.

Vick A, Kraemer RR, Morris JL, Willett LL, Centor RM, Estrada CA, Rodriguez JM.

J Gen Intern Med. 2012 Jun;27(6):747-51. doi: 10.1007/s11606-011-1928-x. No abstract available.

0

0

0

PUBMED

Clinical severity of Huntington's disease does not always correlate with neuropathologic stage.

Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J.

Mov Disord. 2012 Aug;27(9):1099-103. doi: 10.1002/mds.25026.

0

0

0

PUBMED

Chorea-acanthocytosis presenting as motor neuron disease.

Neutel D, Miltenberger-Miltenyi G, Silva I, de Carvalho M.

Muscle Nerve. 2012 Feb;45(2):293-5. doi: 10.1002/mus.22269. Erratum in: Muscle Nerve. 2012 Mar;45(3):456.

0

0

0

PUBMED

Huntington's disease: how intermediate are intermediate repeat lengths?

Squitieri F, Jankovic J.

Mov Disord. 2012 Dec;27(14):1714-7. doi: 10.1002/mds.25172.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy